Congratulations to Jean Albrengues and Lætitia Seguin, who were awarded the prize for the 15th Call for Projects by the Bristol Myers Squibb Foundation for Research in Immuno-Oncology for their work on “reprogramming the tumor microenvironment through neutrophils to restore the efficacy of immunotherapy”.

Pour en savoir plus sur ces travaux. Retrouvez l’interview ici